Cargando…
E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess
PURPOSE: E47 has been identified as a modulating transcription factor of glucocorticoid receptor target genes, its loss protecting mice from metabolic adverse effects of glucocorticoids. We aimed to analyze the role of E47 in patients with endogenous glucocorticoid excess [Cushing’s syndrome (CS)] a...
Autores principales: | Zhang, Wei, Nowotny, Hanna, Theodoropoulou, Marily, Simon, Julia, Hemmer, Charlotte M., Bidlingmaier, Martin, Auer, Matthias K., Reincke, Martin, Uhlenhaut, Henriette, Reisch, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691538/ https://www.ncbi.nlm.nih.gov/pubmed/38047107 http://dx.doi.org/10.3389/fendo.2023.1249863 |
Ejemplares similares
-
Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study
por: Vogel, Frederick, et al.
Publicado: (2021) -
E47 modulates hepatic glucocorticoid action
por: Hemmer, M. Charlotte, et al.
Publicado: (2019) -
Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess
por: Vogel, Frederick, et al.
Publicado: (2021) -
Glucocorticoid Receptors Are Making a Comeback in Corticotroph Tumorigenesis
por: Theodoropoulou, Marily
Publicado: (2021) -
Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe
por: Martin, Claire S., et al.
Publicado: (2021)